Fuji Pharma Invests US$50 Million In Alvotech

Melon slices
Fuji Pharma takes a slice of Alvotech for US$50 million • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products